This leading deadly disease is generally divided into luminal A, luminal B, HER2/ErbB2-positive, and triple-negative breast cancer subtypes according to the expression status of estrogen receptor, progesterone receptor, and HER2/ErbB2 [36]. This evidence concerns the gene PGR and triple-negative breast carcinoma.